Corticosteroid therapy for patients with CoVID-19 pneumonia: a before-after study.

Date publication

juillet 2020

Journal

International journal of antimicrobial agents

Auteurs

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/32634602

Résumé

Anti-inflammatory drugs such as corticosteroids may beneficially modulate the host inflammatory response to CoVID-19 pneumonia.

Mots clés

COVID-19, COVID-19 pneumonia, Corticosteroid, SARS CoV2

Référence

Int. J. Antimicrob. Agents. 2020 Jul 4;:106077